Waters M. Kevin's Insider Trades & SAST Disclosures
Waters M. Kevin's most recent trade in Procept BioRobotics Corp was a trade of 733 Common Stock done at an average price of $57.1 . Disclosure was reported to the exchange on March 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Waters M. Kevin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 57.06 per share. | 18 Mar 2025 | 733 | 107,991 | - | 57.1 | 41,825 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 61.31 per share. | 06 Mar 2025 | 3,662 | 108,724 | - | 61.3 | 224,517 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 16,290 | 112,386 | - | 0 | Common Stock | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 14,388 | 14,388 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 15 Oct 2024 | 25,000 | 121,096 | - | 4.6 | 114,000 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 25,000 | 19,160 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 72.11 per share. | 15 Oct 2024 | 15,959 | 105,137 | - | 72.1 | 1,150,803 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 73.02 per share. | 15 Oct 2024 | 8,115 | 97,022 | - | 73.0 | 592,557 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 73.75 per share. | 15 Oct 2024 | 926 | 96,096 | - | 73.8 | 68,293 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 82.69 per share. | 16 Sep 2024 | 17,977 | 96,496 | - | 82.7 | 1,486,518 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 16 Sep 2024 | 15,917 | 112,013 | - | 4.5 | 71,945 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 15,917 | 0 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 16 Sep 2024 | 9,083 | 121,096 | - | 4.6 | 41,418 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 9,083 | 44,160 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 81.96 per share. | 16 Sep 2024 | 6,623 | 114,473 | - | 82.0 | 542,821 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 83.35 per share. | 16 Sep 2024 | 400 | 96,096 | - | 83.4 | 33,340 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 48.83 per share. | 18 Mar 2024 | 1,024 | 102,149 | - | 48.8 | 50,002 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 15 Mar 2024 | 36,010 | 85,426 | - | 4.5 | 162,765 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 36,010 | 15,917 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 15 Mar 2024 | 17,747 | 103,173 | - | 4.6 | 80,926 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 17,747 | 53,243 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 19,328 | 52,851 | - | 0 | Common Stock | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 16,835 | 16,835 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 13,275 | 46,798 | - | 0 | Common Stock | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 11,563 | 11,563 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 46.67 per share. | 06 Mar 2024 | 3,435 | 49,416 | - | 46.7 | 160,311 | Common Stock |
| Procept BioRobotics Corp | Waters Kevin M. | EVP, CFO | Sale of securities on an exchange or to another person at price $ 50.16 per share. | 12 Feb 2024 | 22,349 | 33,523 | - | 50.2 | 1,121,062 | Common Stock |
| Procept BioRobotics Corp | M. Kevin Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 22,349 | 51,927 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Waters M. Kevin | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 12 Feb 2024 | 22,349 | 55,872 | - | 4.5 | 101,017 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 28,677 | 74,276 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | M. Waters Kevin | EVP, CFO | Sale of securities on an exchange or to another person at price $ 50.09 per share. | 07 Feb 2024 | 28,677 | 33,523 | - | 50.1 | 1,436,379 | Common Stock |
| Procept BioRobotics Corp | Kevin Waters M. | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 07 Feb 2024 | 28,677 | 62,200 | - | 4.5 | 129,620 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 07 Feb 2024 | 904 | 33,523 | - | 50 | 45,200 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 07 Feb 2024 | 904 | 34,427 | - | 4.5 | 4,086 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 904 | 102,953 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 09 Jan 2024 | 17,310 | 50,833 | - | 4.5 | 78,241 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 45.07 per share. | 09 Jan 2024 | 17,310 | 33,523 | - | 45.1 | 780,247 | Common Stock |
| Procept BioRobotics Corp | Kevin Waters M. | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 17,310 | 103,857 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | M. Kevin Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 71,465 | 121,167 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin Waters M. | EVP, CFO | Sale of securities on an exchange or to another person at price $ 40.05 per share. | 13 Dec 2023 | 71,465 | 33,523 | - | 40.1 | 2,862,216 | Common Stock |
| Procept BioRobotics Corp | M. Kevin Waters | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 13 Dec 2023 | 71,465 | 104,988 | - | 4.5 | 323,022 | Common Stock |
| Procept BioRobotics Corp | Waters Kevin M. | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 6,888 | 192,632 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Waters M. Kevin | EVP, CFO | Sale of securities on an exchange or to another person at price $ 40.02 per share. | 06 Dec 2023 | 6,888 | 33,523 | - | 40.0 | 275,640 | Common Stock |
| Procept BioRobotics Corp | M. Waters Kevin | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 06 Dec 2023 | 6,888 | 48,608 | - | 4.5 | 31,134 | Common Stock |
| Procept BioRobotics Corp | Kevin Waters M. | EVP, CFO | Sale of securities on an exchange or to another person at price $ 40.02 per share. | 06 Dec 2023 | 4,360 | 44,248 | - | 40.0 | 174,493 | Common Stock |
| Procept BioRobotics Corp | Kevin Waters M. | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 06 Dec 2023 | 4,360 | 37,883 | - | 4.5 | 19,707 | Common Stock |
| Procept BioRobotics Corp | Waters M. Kevin | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 4,360 | 203,357 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | M. Kevin Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 06 Dec 2023 | 3,837 | 40,411 | - | 40 | 153,480 | Common Stock |
| Procept BioRobotics Corp | M. Waters Kevin | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 3,837 | 199,520 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin Waters M. | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.52 per share. | 06 Dec 2023 | 3,837 | 41,720 | - | 4.5 | 17,343 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 35.12 per share. | 15 Jun 2023 | 22,631 | 33,523 | - | 35.1 | 794,912 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 31.84 per share. | 16 Mar 2023 | 706 | 56,154 | - | 31.8 | 22,479 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 34.36 per share. | 07 Mar 2023 | 22,046 | 57,678 | - | 34.4 | 757,547 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 34.15 per share. | 07 Mar 2023 | 7,136 | 79,724 | - | 34.2 | 243,705 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Sale of securities on an exchange or to another person at price $ 35.16 per share. | 07 Mar 2023 | 818 | 56,860 | - | 35.2 | 28,757 | Common Stock |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 47,732 | 47,732 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 26,315 | 86,860 | - | 0 | Common Stock | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 16,020 | 16,020 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Kevin M. Waters | EVP, CFO | Grant, award, or other acquisition of securities at price $ 29.38 per share. | 31 Mar 2022 | 7,914 | 60,545 | - | 29.4 | 232,513 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges